Acquisition of Aquarius Biotechnologies, Inc. (Details 1) - USD ($)		Sep. 30, 2015	Jan. 29, 2015	Dec. 31, 2014
Business Acquisition [Line Items]
Goodwill		$ 1,384,674		$ 0
Net assets acquired			$ 2,873,035
Aquarius Biotechnologies, Inc. [Member]
Business Acquisition [Line Items]
Cash			70,754
Contract/ Grant receivable			45,644
Prepaid expenses and other current assets			5,084
Equipment, net			5,051
Other assets			700
In-process research and development	[1]		3,017,377
Total identifiable assets			3,144,610
Accounts payable			300,413
Notes payable	[2]		10,000
Accrued expenses			92,509
Total liabilities assumed			402,922
Net identifiable assets acquired			2,741,688
Goodwill	[3]		1,384,674
Deferred income taxes arising from basis differences of tax aspects of in-process research and development			(1,253,327)
Net assets acquired			$ 2,873,035

[1] The fair value of the in-process research and development asset was estimated on the basis of its replacement cost as determined by a buildup of the costs incurred to develop the technology as it existed as of the acquisition date resulting in a fair value of $3,017,377. The fair value of other assets and liabilities approximate their book value.

[2] Aquarius issued a note for a loan that was made to a related party. Interest on note is calculated using the applicable federal rate for midterm loans. Since the note has no specified repayment terms, it is considered a current liability.

[3] The Company allocated the purchase price to the net tangible and intangible assets based upon their estimated fair values at the Merger date. The excess of the purchase price over the estimated fair values of the net tangible and intangible assets acquired has been recorded as goodwill including deferred tax liabilities resulting from the tax attributes of the in-process research and development (see Note C [14]).